The terminology and classification scheme of acute pancreatitis proposed at the initial Atlanta Symposium was reviewed, and a new consensus statement was recently proposed. Major changes include subdividing acute fluid collections in the first 4 weeks into ''acute peripancreatic fluid collection'' and ''acute necrotic collection'' based on the presence of necrotic debris. Delayed fluid collections have been similarly subdivided into ''pseudocyst'' and ''walled-off necrosis.'' Correct use of the new terms that describe these collections is important because they lead to different treatment decisions. The purpose of this article is to present an overview of fluid collections associated with acute pancreatitis, with an emphasis on their prognostic significance and impact on clinical management, and to illustrate the new terminology.
Acute pancreatitis is an acute inflammatory disease of the pancreas that may also involve peripancreatic tissues and even remote organs. Different clinical or radiologic scoring systems to predict severity and outcome in acute pancreatitis have been developed since the early 1980s. In 1992, the Atlanta Symposium developed a consensus statement that defined both severe acute pancreatitis and its complications [1] . Recently, the terminology and classification scheme proposed at the initial Atlanta Symposium was reviewed, and a new consensus statement proposed [2] . Major changes include subdividing acute fluid collections in the first 4 weeks into ''acute peripancreatic fluid collection'' (APFC) and ''acute necrotic fluid collection'' (ANC) based on the presence of necrotic debris. Delayed fluid collections have been similarly subdivided into ''pseudocyst'' and ''walledoff necrosis'' (WON). The terms such as pancreatic abscess and phlegmon have been abandoned [2] . Appropriate use of the new terms that describe the fluid collections is important for management decision making for patients with acute pancreatitis [3] .
Currently, contrast-enhanced computed tomography (CT) is the mainstay of imaging in evaluating the extend and evolution of acute pancreatitis and its complications [4] . The main role of magnetic resonance imaging (MRI) is in the assessment of fluid collections for the presence of solid necrotic debris in patients for whom drainage is being considered, because CT may show fluid that appears to be moderately homogeneous and fail to detect necrotic debris [5, 6] . MRI is also useful for those patients with contrast allergy or renal insufficiency and as magnetic resonance cholangiopancreatography for the assessment of a disconnected pancreatic duct. The purpose of this article is to illustrate the new terminology for fluid collections in acute pancreatitis and to show their prognostic significance and impact on treatment.
APFCs
APFC is a collection of enzyme-rich pancreatic juice predominantly collected adjacent to the pancreas. It develops within the first 48 hours in 30%-50% of patients with acute pancreatitis [7] . APFC is most frequently collected in the lesser sac but may be seen in the anterior pararenal space (most commonly, left); transverse mesocolon; mesenteric root; and gastrohepatic, gastrosplenic, and gastrocolic ligaments ( Figure 1 ). Most of the APFCs remain sterile and disappear spontaneously within 2-4 weeks in 50% of the patients. When APFCs do not resolve, they evolve into pseudocysts after 4 weeks or more but occasionally sooner [7] .
In the first week of acute pancreatitis, differentiation between APFC and ANCs may be difficult because both fluid collections may appear as areas of nonenhancement. If nonenhancing components of variable attenuation are seen in these collections, then the diagnosis of peripancreatic necrosis with nonliquified components (hemorrhage, fat, and/or necrotic fat) is suggested [3] .
Pancreatic Pseudocysts
Pancreatic pseudocyst is defined as a fluid collection of pancreatic juice enclosed by a nonepithelialized wall of fibrous or granulation tissue [1] . Formation of a pseudocyst usually requires at least 4 weeks from the onset of interstitial oedematous pancreatitis, and they occur in approximately 10%-20% of cases. Pseudocysts usually develop in the lesser sac, although they may be seen in anywhere from the mediastinum to the pelvis or even present in the thigh ( Figures 1B and 2 ) [8] . On contrast-enhanced CT, pseudocysts are usually seen as a thin-walled (1-2 mm), round or oval cystic lesion, with a density <20 HU [7] . Their walls may be thick and irregular, and develop calcification over the time. Pseudocysts are uniloculated, encapsulated fluid collections that are seen as hypotense on T1-weighted and hyperintense on T2-weighted images ( Figure 3 ). Enhancement may be observed in the walls on contrast-enhanced CT or MRI [9] . Pancreatic pseudocysts have been reported to communicate with the pancreatic duct in 25%-58% of cases [7, 8] .
Approximately 50% of pseudocysts are asymptomatic and resolve spontaneously over time [7, 8] . Occasionally, spontaneous drainage into adjacent stomach or transverse colon may develop [10] . Only half of the nonspontaneously resolved pseudocyts cause clinical symptoms or complications such as pain, secondary infection, hemorrhage related to the erosion of adjacent vessels, systemic inflammatory response syndrome due to the rupture into the peritoneal cavity, and bile duct obstruction or gastric outlet obstruction due to the mass effect [10] . Pseudocysts should be treated with percutaneous or endoscopic drainage or with surgery if they are symptomatic, their size is larger than 5 cm or gradually increasing, and if they persist longer than 6 weeks [10] .
According to the new definition, pancreatic pseudocysts should be described as noninfected or infected. Infected (suppurative) pseudocyst is the new name for what had been described in the Atlanta Symposium as a pancreatic abscess [1, 2] . An infected pseudocyst is a well-circumscribed, puscontaining, encapsulated fluid collection near the pancreas. The only reliable sign of an infected pseudocyst on CT is gas, with or without fluid levels within the lesion, being seen in approximately 20% of infected pseudocysts ( Figure 4 ). On contrast-enhanced CT images, a thick and irregular wall to a pseudocyst will raise concern about infection but is not reliable. Needle aspiration is often required to make the diagnosis, preferably from behind, and to avoid transgressing the peritoneum, stomach, or duodenum [3] . Plentiful gas in such a lesion may occasionally be due to enteric fistula without infection [3, 10] .
ANCs
ANCs may be pancreatic (5%), peripancreatic alone (20%), and mixed (75%-80%) [3] . They develop as a result of the pancreatic glandular and/or peripancreatic fatty tissue necrosis to become liquefied over time. These collections contain liquefied, necrotic fatty tissue, and pancreatic and extrapancreatic solid necrotic debris ( Figures 5 and 6 ) [2] . Whether their content is solid or liquid depends on the time elapsed since the onset of the disease. Within the first weeks of onset of the acute necrotizing pancreatitis, any collection in the pancreas that replaces pancreatic parenchyma should be considered an ANC and not a pseudocyst. ANCs are often connected to the main pancreatic duct because they show an association with the disrupted integrity of the pancreatic duct ( Figure 7) . Collection content may be sterile or infected (Figure 8 ). 
WONs
Similar to the development of a pseudocyst from APFC over time, WON evolves from the ANC and results in the development of a nonepithelialized thick wall between the necrosis and the adjacent viable tissue after 4 or more weeks [2] . WON replaces the formerly used terms of ''organized pancreatic necrosis,'' ''pseudocyst associated with necrosis,'' ''central cavitary necrosis,'' and ''necroma.'' Similar to ANC, WON may involve the pancreatic parenchymal tissue and/or peripancreatic tissue. Any apparent fluid collection that occupies or replaces portions of the pancreatic parenchyma should be called a WON after 4 weeks from onset of acute necrotizing pancreatitis. WON is an irregular, partially liquefied collection that may contain solid necrotic debris and may expand to the peripancreatic space ( Figures 6, 9 , and 10) [11] . Solid components in these collections are identified better on ultrasound and T2weighted MRIs than on CT (Figures 6D, 10B , and 10C) [5] . Collection content may be sterile or infected (Figure 11 ). In the absence of gas within the collection, a diagnosis of infection can be obtained only by performing fine needle aspiration of the collection with a positive Gram stain and culture for bacteria or fungal organisms.
In the past, evolving necrotic collections, now termed WONs, have been mistaken for pseudocysts. The presence or absence of necrosis in the CT performed in the beginning of acute pancreatitis and clinical course enables the differentiation of WON from a pseudocyst, although sometimes this may be difficult [11] . Differentiation of these 2 clinical conditions is of importance because each of them has a different treatment. The ideal treatment of WON is controversial, and most centres prefer the treatment with operative necrosectomy in the infected or symptomatic cases. However, laparoscopic, percutaneous, and endoscopic transgastric or transduodenal approaches have recently been used with increasing frequency in the treatment of this clinical situation. Although multiple large-bore catheters and aggressive irrigation are required to discharge the solid components in the cavity for endoscopic treatment of WON, simple drainage with a single catheter is mostly sufficient for symptomatic and infected pseudocysts [12] . Findings that favor a WON include a larger size, extension to the paracolic or retrocolic space, an irregular wall definition, the presence of solid or fat attenuation debris, the presence of pancreatic parenchymal deformity and discontinuity, and the absence of dilatation of the main pancreatic duct (Figures 6, (9) (10) (11) [11] . Dilatation of the main pancreatic duct caused by the compression of the pancreatic parenchyma by pseudocyst or due to proximal ductal stricture is a finding in favor of a pseudocyst ( Figure 2B ) [11] .
Conclusions
Acute pancreatitis is associated with a wide variety of complications. Contrast-enhanced CT is the primary imaging modality for initially identifying local complications and for evaluating response to management. MRI is at least as effective as CT in the detection of the presence, localization, and extension of fluid collections, although this method is superior to CT in the evaluation of the content of fluid collections and specifically to differentiate a WON from a pseudocyst. Ultrasound may be helpful when there is concern about whether a pseudocyst or a WON is the right diagnosis, especially if MRI is not readily available. The radiologists should identify the presence, localization, and extension of pancreatic and extrapancreatic fluid collections, and should use the currently accepted terms that describe the varied fluid collections because this is important because they dictate treatment options. 
